Prognostic value of HLA class I expression in patients with cutaneous melanoma and soft tissue sarcomas treated with cancer-testis antigens-based vaccine

Prognostic value of HLA class I expression in patients with cutaneous melanoma and soft tissue sarcomas treated with cancer-testis antigens-based vaccine

Aim: To assess the predictive and prognostic role of HLA class I expression in patients with melanoma (Mel), and soft tissue sarcomas (STS) treated with autologous dendritic cell vaccine (DCV) (CaTeVac). Methods: From 2009 to 2023, 277 patients with Mel (143), and STS (134), received DCV at the N.N....

Full description

Saved in:
Bibliographic Details
Main Authors: Tatiana L. Nekhaeva, Aleksei V. Novik, Dmitry V. Girdyuk, Anna B. Danilova, Polina A. Savchenko, Alina V. Grigoryevskaya, Maria A. Nekrasova, Natalia A. Efremova, Andrey V. Orekhov, Irina A. Baldueva
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2025-02-01
Series:Exploration of Medicine
Subjects:
oncology
immunotherapy
dendritic cell vaccine
biosamples
prognostic markers
predictive markers
immunological efficacy
human leukocyte antigens
Online Access:https://www.explorationpub.com/uploads/Article/A1001287/1001287.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.explorationpub.com/uploads/Article/A1001287/1001287.pdf

Similar Items